Covid-19 Has Made Online Learning A Credible Source Of Education

Bridging the skill gap between industry requirements and the talent pool available in the pharma world is becoming increasingly important. Romola Pinto, who leads the Rubicon Academy team and also heads the HR function at Rubicon Research, speaks about the transformation that pharma education and training is undergoing after the onset of COVID-19 and explains how Rubicon Academy is training, reskilling and upskilling pharma talent to meet the changing demands and emerging needs of the industry, in an interaction with Lakshmipriya Nair

- Lakshmipriya Nair

Innovation has become a byword in every field today. How can we apply it to pharmacy education and training?

There is tremendous scope and need for innovation in pharma. However, since human lives are at stake all innovation must be within the regulatory framework. Therefore, training forms a crucial part of any candidate’s career in the industry. However, classroom training cannot be the only way to impart knowledge. Integration of on-the-job training with conceptual learning, whether in the laboratory or outside it, has to be in the context of today’s technology-driven world. Social distancing and remote learning have become the new normal. Integrating that into our lives can be viewed as a positive reality.

At Rubicon Academy, we aim to provide a holistic learning experience with a focus on enabling pharma professionals to improve their job performance and gain skills needed to do different kinds of jobs. Our content will be relevant to a wide range of participants— from fresh graduates to experienced professionals who want to stay updated or make lateral movements to different departments.

Innovation, quality and care are the three tenets of our parent company, Rubicon Research. We approach all initiatives keeping these in mind. We pride ourselves on having the right mix of industry experience, academic rigor and intent to make a positive change in the quality of talent available in the pharmaceutical space.

What role does Rubicon Academy envisage for itself in the creation of an innovative ecosystem for the life sciences sector in India?